share_log

三葉草生物-B：截至2023年12月31日止月份股份發行人的證券變動月報表

CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended December 31, 2023

Hong Kong Stock Exchange ·  Jan 3 11:03
Summary by Futu AI
三葉草生物製藥有限公司（「三叶草生物-B」）於2024年1月3日向香港交易及結算所有限公司提交了截至2023年12月31日的證券變動月報表。報告顯示，公司的法定/註冊股本維持不變，上月底及本月底結存均為2,000,000,000股，每股面值0.0001美元，總額200,000美元。在股份期權方面，根據首次公開發售前後的購股權計劃，本月內有712,000股份期權被行使，並因此發行了相同數量的新股份。本月內因行使期權所得資金總額為5,696港元。該報告亦確認了所有相關的上市規則要求均已遵守。
三葉草生物製藥有限公司（「三叶草生物-B」）於2024年1月3日向香港交易及結算所有限公司提交了截至2023年12月31日的證券變動月報表。報告顯示，公司的法定/註冊股本維持不變，上月底及本月底結存均為2,000,000,000股，每股面值0.0001美元，總額200,000美元。在股份期權方面，根據首次公開發售前後的購股權計劃，本月內有712,000股份期權被行使，並因此發行了相同數量的新股份。本月內因行使期權所得資金總額為5,696港元。該報告亦確認了所有相關的上市規則要求均已遵守。
Clover Biopharmaceuticals Limited (“Clover Bio-B”) filed with Hong Kong Trading and Clearing Limited on 3 January 2024 its Statement of Monthly Changes in Securities for the year ended 31 December 2023. The report shows that the company's regulated/registered share capital remained unchanged, with 2,000,000,000 shares outstanding at the end of last month and at the end of this month, with a face value of $0.0001 per share for a total amount of $200,000. In terms of stock options, 712,000 share options were exercised during the month under the IPO and as a result the same number of new shares were issued. The total amount of capital received from the exercise of options during the month was HK$5,696. The report also confirms that all relevant listing rules requirements have been complied with.
Clover Biopharmaceuticals Limited (“Clover Bio-B”) filed with Hong Kong Trading and Clearing Limited on 3 January 2024 its Statement of Monthly Changes in Securities for the year ended 31 December 2023. The report shows that the company's regulated/registered share capital remained unchanged, with 2,000,000,000 shares outstanding at the end of last month and at the end of this month, with a face value of $0.0001 per share for a total amount of $200,000. In terms of stock options, 712,000 share options were exercised during the month under the IPO and as a result the same number of new shares were issued. The total amount of capital received from the exercise of options during the month was HK$5,696. The report also confirms that all relevant listing rules requirements have been complied with.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.